> Real-time Quotes & News

Real-time Quotes

Product
Bid
Ask
High
Low
Previous Close
*The above quotes are for reference only

Real-time News

2026-10-27

Qianhong Pharmaceutical said at an earnings briefing that its QHRD106 injection for acute ischemic stroke is in the closing stage of Phase IIb trials. After completing communications with China’s Center for Drug Evaluation (CDE), the The company will

Qianhong Pharmaceutical said at an earnings briefing that its QHRD106 injection for acute ischemic stroke is in the closing stage of Phase IIb trials. After completing communications with China’s Center for Drug Evaluation (CDE), the The company will promptly advance Phase III trials and related marketing-authorization filings.
2026-10-27

China's National Joint Drug Procurement Office on Oct. 26 revoked the national procurement winning status for letrozole tablets produced by Eugia Pharma Specialities Limited and gadoterate meglumine injection produced by JSC Farmak. The office said b

China's National Joint Drug Procurement Office on Oct. 26 revoked the national procurement winning status for letrozole tablets produced by Eugia Pharma Specialities Limited and gadoterate meglumine injection produced by JSC Farmak. The office said both applicants recently reported they could not continue to supply the products and, after supervisory interviews, still failed to meet medical institutions' demand. Eugia and its applicant Hangzhou Ketu Supply Chain Co. were placed on the violations list and barred from participating in national drug procurement for four years; JSC Farmak and its applicant Shanghai Liyi Pharmaceutical Technology Co. were likewise listed and barred for two years.
2026-10-27

Moody's analyst said future rating actions will depend on whether Japan's recent resilience can withstand future shocks.

Moody's analyst said future rating actions will depend on whether Japan's recent resilience can withstand future shocks.
2026-10-27

Moody's analysts: Future rating actions depend on whether Japan's latest resilience can withstand future shocks.

Moody's analysts: Future rating actions depend on whether Japan's latest resilience can withstand future shocks.
2026-10-27

MOODY'S sovereign analyst says Japan is showing signs of sustained growth and stable inf.

MOODY'S sovereign analyst says Japan is showing signs of sustained growth and stable inf.
2026-10-27

Moody's sovereign analysts: Japan is showing signs of sustained growth and stable inflation.

Moody's sovereign analysts: Japan is showing signs of sustained growth and stable inflation.
Previous 1 ... 313 314 315 316 317 ... 319 Next